| Code | Description | Claims | Beneficiaries | Total Paid |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
24,074 |
22,434 |
$983K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,900 |
11,515 |
$694K |
| 99215 |
Prolong outpt/office vis |
8,945 |
8,711 |
$667K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,171 |
623 |
$538K |
| 95886 |
|
4,621 |
3,740 |
$466K |
| 62323 |
|
2,570 |
2,497 |
$287K |
| 95911 |
|
2,435 |
2,333 |
$282K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
22,287 |
20,883 |
$260K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,579 |
2,324 |
$239K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,990 |
3,161 |
$234K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,182 |
3,161 |
$224K |
| 95910 |
|
2,151 |
2,120 |
$209K |
| 62321 |
|
1,752 |
1,687 |
$180K |
| 76942 |
|
7,310 |
6,238 |
$177K |
| 95812 |
|
952 |
949 |
$175K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,612 |
1,450 |
$159K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,635 |
1,626 |
$142K |
| 72141 |
|
1,571 |
1,436 |
$141K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,474 |
3,328 |
$137K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
6,671 |
5,614 |
$132K |
| 99205 |
Prolong outpt/office vis |
1,197 |
1,179 |
$126K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
714 |
638 |
$112K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,638 |
13,478 |
$97K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,259 |
1,544 |
$96K |
| 20611 |
|
2,198 |
1,714 |
$84K |
| 64505 |
|
604 |
418 |
$53K |
| 70544 |
|
490 |
473 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,593 |
802 |
$47K |
| 20553 |
|
1,622 |
1,578 |
$47K |
| 64635 |
|
304 |
236 |
$44K |
| 72110 |
|
1,670 |
1,499 |
$43K |
| 64483 |
|
455 |
369 |
$40K |
| 90834 |
Psychotherapy, 45 minutes with patient |
814 |
627 |
$40K |
| 97162 |
|
688 |
683 |
$37K |
| 72050 |
|
1,189 |
1,052 |
$32K |
| 64400 |
|
621 |
422 |
$30K |
| 77002 |
|
531 |
407 |
$30K |
| 92546 |
|
478 |
359 |
$30K |
| 64405 |
|
768 |
669 |
$28K |
| 62370 |
|
576 |
542 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,495 |
12,644 |
$24K |
| 64636 |
|
359 |
248 |
$22K |
| 64615 |
|
345 |
344 |
$19K |
| 64484 |
|
450 |
370 |
$17K |
| 64451 |
|
173 |
154 |
$16K |
| 27096 |
|
241 |
207 |
$15K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,590 |
802 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
890 |
424 |
$14K |
| 64493 |
|
166 |
109 |
$14K |
| 99490 |
Ccm add 20min |
1,442 |
1,431 |
$13K |
| 20610 |
|
524 |
414 |
$12K |
| 95930 |
|
288 |
288 |
$10K |
| 72114 |
|
308 |
302 |
$10K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
354 |
129 |
$10K |
| 20526 |
|
266 |
205 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
84 |
64 |
$8K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
13 |
12 |
$8K |
| 76080 |
|
272 |
117 |
$8K |
| 64490 |
|
78 |
62 |
$8K |
| 72156 |
|
53 |
51 |
$8K |
| 64494 |
|
168 |
108 |
$7K |
| 92653 |
|
139 |
139 |
$7K |
| 82962 |
|
3,579 |
2,249 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,659 |
6,588 |
$7K |
| 90791 |
Psychiatric diagnostic evaluation |
87 |
87 |
$6K |
| 72052 |
|
216 |
213 |
$6K |
| 72070 |
|
322 |
301 |
$5K |
| 70549 |
|
25 |
25 |
$5K |
| 97164 |
|
136 |
132 |
$5K |
| 92585 |
|
74 |
74 |
$5K |
| 99223 |
Prolong inpt eval add15 m |
54 |
50 |
$5K |
| 97035 |
|
666 |
206 |
$4K |
| 72146 |
|
42 |
34 |
$4K |
| 92542 |
|
192 |
192 |
$3K |
| 73221 |
|
26 |
25 |
$3K |
| 73564 |
|
100 |
83 |
$3K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
535 |
497 |
$3K |
| 92540 |
|
38 |
37 |
$2K |
| 64495 |
|
63 |
40 |
$2K |
| 92547 |
|
479 |
359 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
102 |
76 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,462 |
6,634 |
$1K |
| 96130 |
|
16 |
15 |
$978.53 |
| 99408 |
|
78 |
73 |
$970.69 |
| 64633 |
|
18 |
12 |
$932.27 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,460 |
738 |
$908.97 |
| 20551 |
|
39 |
36 |
$851.66 |
| 72074 |
|
40 |
40 |
$815.03 |
| 73030 |
|
77 |
52 |
$679.84 |
| 73502 |
|
27 |
26 |
$670.28 |
| 72157 |
|
12 |
12 |
$627.00 |
| 97014 |
|
75 |
37 |
$499.72 |
| 96136 |
|
15 |
15 |
$368.89 |
| 94760 |
|
12,269 |
8,678 |
$329.57 |
| 73503 |
|
12 |
12 |
$289.20 |
| 96138 |
|
13 |
12 |
$197.46 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
1,204 |
962 |
$93.34 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
13 |
13 |
$83.86 |
| J1815 |
Injection, insulin, per 5 units |
14 |
12 |
$75.62 |
| 99358 |
Prolong nursin fac eval 15m |
60 |
59 |
$66.39 |
| 99406 |
|
12 |
12 |
$48.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
46 |
38 |
$40.16 |
| A4615 |
Cannula, nasal |
224 |
165 |
$10.87 |
| H0049 |
Alcohol and/or drug screening |
324 |
319 |
$0.00 |
| G9854 |
Patient was not admitted to the icu in the last 30 days of life |
60 |
59 |
$0.00 |
| 97010 |
|
142 |
73 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
289 |
247 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
36 |
36 |
$0.00 |